![Xu Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Wei
Directeur/Membre du Conseil chez AnHeart Therapeutics (Hangzhou) Co., Ltd.
Postes actifs de Xu Wei
Sociétés | Poste | Début | Fin |
---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Xu Wei
Statistiques
Internationale
Chine | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |